-87.1%
SNDQ vs MRNA
+334.1%
-421.2%
-96.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +44.4% | -6.5% | +50.9% | +44.4% |
| 7D | +116.9% | +8.4% | +108.5% | +116.5% |
| 30D | +205.2% | +28.8% | +176.4% | +202.3% |
| 3M | +45.4% | +329.2% | -283.8% | +43.2% |
| 6M | -66.2% | +416.9% | -483.2% | -49.2% |
| All | -87.1% | +334.1% | -421.2% | -82.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling